Post-traumatic Stress Disorder (PTSD) Treatment Market Share

  • Report ID: 6496
  • Published Date: Sep 18, 2025
  • Report Format: PDF, PPT

Post-traumatic Stress Disorder Treatment Market Regional Analysis:

North America Market Insights

North America industry is poised to hold largest revenue share of 40.7% by 2035. The market growth is expected on account of the high rate of PTSD prevalence and the rising need for mental health care. PTSD affects a significant portion of population in the region, including veterans, first responders, and survivors of trauma, leading to increased demand for effective treatments.

The PTSD treatment market is expanding in the U.S. due to several factors, including rising government financing for mental health programs, increased awareness of the value of mental health, and an increase in the number of mental health practitioners. Also, there is a rising shift towards positivity among people regarding mental health. According to a 2019 survey by the American Psychological Association, 87% of adults in the U.S. concur that having a mental health illness is nothing to be ashamed of, and 86% stated that they think people with mental health illnesses are capable of recovering.

In Canada, the funding of mental health services and programs has increased since the government declared mental health a high priority. For instance, in 2023, the Canadian Institutes of Health Research (CIHR) funded 25 research projects with about USD 5 million to investigate current norms, best practices, and policies for providing mental health and drug-use services to teenagers, children, and young people. Furthermore, the market is expanding due to the rising demand for mental health services and the availability of cutting-edge therapies such as virtual reality therapy.

Europe Market Insights

The PTSD treatment market in Europe will hold the second-largest revenue share during the forecast period. The market is growing in the region owing to the increasing incidences of PTSD and surging demand for mental health services. For instance, the majority of people in Europe roughly two-thirds have at least one traumatic incident in their lifetime.

The UK post-traumatic stress disorder (PTSD) treatment market is expanding due to several factors, including rising government funding for mental health initiatives, expanding awareness of the value of mental health, and the accessibility of cutting-edge therapies that include, Eye Movement Desensitization and Reprocessing (EMDR). The government stated that by April 2024, an additional USD 2.57 billion in funding will be provided annually to expand and reform mental health services in England, enabling 2 million more individuals to receive the necessary mental health assistance.

In Germany, improving the nation's mental health and quality of life are top priorities. The need for efficient therapies is driven by the emphasis on mental health as a vital aspect of total well-being. The industry is expanding due to the initiatives to improve mental health care and promote wellbeing.

Post-traumatic Stress Disorder Treatment Market share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of post-traumatic stress disorder treatment is assessed at USD 2.14 billion.

The global post-traumatic stress disorder treatment market size surpassed USD 2.04 billion in 2025 and is projected to grow at a CAGR of over 5.7%, reaching USD 3.55 billion revenue by 2035.

North America post-traumatic stress disorder (PTSD) treatment market will account for 40.70% share by 2035, attributed to high PTSD prevalence and demand for mental health care.

Key players in the market include Jazz Pharmaceuticals plc, Bionomics Limited, Merck KGaA, Pfizer Inc., Aurobindo Pharma Limited, GlaxoSmithKline plc (GSK plc), Viatris Inc., Jubilant Pharmova Ltd., H. Lundbeck A/S, Camber Pharmaceuticals, Inc..
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos